EA
IONS icon

Emerald Acquisition’s Ionis Pharmaceuticals IONS Stock Holding History

Emerald Acquisition’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$706K Sell
19,268
-35,308
-65% -$1.1M ﹤0.01% 2295
2016
Q2 		$1.27M Buy
+54,576
New +$1.76M ﹤0.01% 2044

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Emerald Acquisition's IONS Position: Q3 2016 in Review

Emerald Acquisition reduced its Ionis Pharmaceuticals (IONS) stake by 65% in Q3 2016, selling an estimated $1.1M and leaving 19,268 shares worth $706K. The position accounts for ﹤0.01% of the portfolio, ranked #2295.

Emerald Acquisition first reported a position in IONS in Q2 2016 and has held it in 2 quarters since. The position peaked at $1.27M in Q2 2016. 281 funds tracked by Wall St. Rank hold IONS as of Q3 2016.

  • Emerald Acquisition held 19,268 shares of Ionis Pharmaceuticals worth $706K as of Q3 2016.
  • Emerald Acquisition sold 35,308 Ionis Pharmaceuticals shares in Q3 2016, an estimated $1.1M.
  • Ionis Pharmaceuticals made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2295 holding.
  • Emerald Acquisition first reported a position in Ionis Pharmaceuticals in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Ionis Pharmaceuticals position peaked at $1.27M in Q2 2016.
  • 281 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.